You understand that companies don't risk billions of dollars on a medical device until it has received FDA approval and generates meaningful revenue? So sad rocko, get a sense of realism in your analysis please! Look at Mako. They didn't get bought out before approval, or before sales. How do you put a value on a device that hasn't generated any sales? It's very ambiguous and big, serious companies don't pull off the kind of bs you and suckitup blast on the board. Can we put the buyout rumors prior to fda approval to rest please?
I won't even waste my time responding to trxc is crap statement
I have looked at many articles that say "Robotics will be a 20Billion $ market because of growth" but based on the growth rates it doesn't add up. Maybe they are talking about a $20 billion $ install base?? If anyone can shed some light on this I would appreciate it.
News 
Market Data 
Discover 
